Kajihara Y et al. |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. |
2017 |
Scand. J. Gastroenterol. |
pmid:27806639
|
Yan J et al. |
Survey about the use of clarithromycin in an ENT outpatient department of a tertiary hospital. |
2017 |
Eur Arch Otorhinolaryngol |
pmid:28508178
|
Shaulov A et al. |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. |
2017 |
Am. J. Hematol. |
pmid:27804150
|
DaCosta A et al. |
Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. |
2017 |
J. Cyst. Fibros. |
pmid:28495380
|
Malfertheiner P et al. |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. |
2017 |
Gut |
pmid:27707777
|
Sharifi R et al. |
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori. |
2017 |
Lipids |
pmid:28493185
|
Reddy AB and Reddy ND |
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers. |
2017 |
Drug Res (Stuttg) |
pmid:28449156
|
Aktas AH and Saridag AM |
Liquid Chromatographic-Chemometric Techniques for the Simultaneous HPLC Determination of Lansoprazole, Amoxicillin and Clarithromycin in Commercial Preparation. |
2017 |
J Chromatogr Sci |
pmid:28449104
|
Itskoviz D et al. |
Smoking increases the likelihood of Helicobacter pylori treatment failure. |
2017 |
Dig Liver Dis |
pmid:28427781
|
Koštrun S et al. |
Around the macrolide - Impact of 3D structure of macrocycles on lipophilicity and cellular accumulation. |
2017 |
Eur J Med Chem |
pmid:28410508
|
Giguère S et al. |
Antimicrobial Resistance in . |
2017 |
Microbiol Spectr |
pmid:29052538
|
Giguère S |
Treatment of Infections Caused by Rhodococcus equi. |
2017 |
Vet. Clin. North Am. Equine Pract. |
pmid:28161038
|
Berni E et al. |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. |
2017 |
BMJ Open |
pmid:28115334
|
Yatera K et al. |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. |
2017 |
Respir Investig |
pmid:29153420
|
Lee MC et al. |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. |
2017 |
J. Antimicrob. Chemother. |
pmid:29091186
|
Costa S et al. |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection. |
2017 |
Eur J Gastroenterol Hepatol |
pmid:28877088
|
Pryjma M et al. |
Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the Gene. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28874379
|
Takahashi C et al. |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease. |
2017 |
Med Mol Morphol |
pmid:27119723
|
Lee JS et al. |
Implication of species change of Nontuberculous Mycobacteria during or after treatment. |
2017 |
BMC Pulm Med |
pmid:29262802
|
Ruiter R et al. |
Helicobacter pylori resistance in the Netherlands: a growing problem? |
2017 |
Neth J Med |
pmid:29219812
|
Oh ES et al. |
Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers. |
2017 |
J Clin Pharm Ther |
pmid:28806472
|
Kuo YT et al. |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. |
2017 |
Lancet Gastroenterol Hepatol |
pmid:28781119
|
Ramas M et al. |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial. |
2017 |
Gastroenterol Hepatol |
pmid:28780968
|
Painsi C and Lange-Asschenfeldt B |
Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection. |
2017 |
Br. J. Dermatol. |
pmid:28731256
|
Mougari F et al. |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27799212
|
Jeong SH et al. |
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. |
2017 |
Int. J. Infect. Dis. |
pmid:28522316
|
Kishida D et al. |
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus. |
2017 |
Intern. Med. |
pmid:28502947
|
Jung YS et al. |
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28497487
|
Sharman MJ et al. |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28494926
|
O'Brien CR et al. |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases |
2017 |
J. Feline Med. Surg. |
pmid:28438086
|
Tan B et al. |
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. |
2017 |
PLoS ONE |
pmid:28407007
|
Chen D et al. |
Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28167563
|
Olesen JS et al. |
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy. |
2017 |
BMJ Case Rep |
pmid:28137898
|
Chang JY et al. |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. |
2017 |
BMC Gastroenterol |
pmid:28109257
|
Sasaoka Y et al. |
Neonatal apnea with Chlamydia pneumoniae infection. |
2017 |
Pediatr Int |
pmid:28102626
|
Lapa GB et al. |
Two approaches to the use of benzo[c][1,2]oxaboroles as active fragments for synthetic transformation of clarithromycin. |
2017 |
J Enzyme Inhib Med Chem |
pmid:28097898
|
Yeo YH et al. |
First-line eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis. |
2018 |
Gut |
pmid:27670375
|
Suzuki R et al. |
Sinobronchial syndrome treated as intractable asthma. |
2018 |
Pediatr Int |
pmid:30320426
|
Mégraud F |
Antibiotic Resistance Is the Key Element in Treatment of Helicobacter pylori Infection. |
2018 |
Gastroenterology |
pmid:30308190
|
Shinozaki S et al. |
Pre-treatment with proton pump inhibitors decreases the success of primary Helicobacter pylori eradication using a vonoprazan-based regimen. |
2018 |
Kaohsiung J. Med. Sci. |
pmid:30041763
|
Iannone A et al. |
New fecal test for non-invasive detection: A diagnostic accuracy study. |
2018 |
World J. Gastroenterol. |
pmid:30038469
|
Heffernan CB et al. |
Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. |
2018 |
Ann. Otol. Rhinol. Laryngol. |
pmid:30032669
|
Hamza D et al. |
Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance. |
2018 |
Microb. Pathog. |
pmid:30031039
|
Vianna JS et al. |
The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. |
2018 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:29972462
|
Myojin S et al. |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child. |
2018 |
Int. J. Infect. Dis. |
pmid:29966711
|
Liou JM et al. |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. |
2018 |
Gastroenterology |
pmid:29964036
|
Kwofie SK et al. |
Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa. |
2018 |
Molecules |
pmid:29954088
|
Tanabe H et al. |
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29950163
|
Sandri A et al. |
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice. |
2018 |
Virulence |
pmid:29938577
|
Gonzalez-Hormazabal P et al. |
Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa. |
2018 |
BMC Gastroenterol |
pmid:29925321
|
|
Clarithromycin in patients with coronary artery disease. |
2018 |
Med Lett Drugs Ther |
pmid:29913468
|
Li M et al. |
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori. |
2018 |
Helicobacter |
pmid:29873436
|
Blümel B et al. |
Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing. |
2018 |
Helicobacter |
pmid:29873430
|
Ito M et al. |
Phase transitions of antibiotic clarithromycin forms I, IV and new form VII crystals. |
2018 |
Int J Pharm |
pmid:29864514
|
Jin BH et al. |
Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29846770
|
Auesomwang C et al. |
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication. |
2018 |
J. Gastroenterol. Hepatol. |
pmid:29804294
|
Chai KY et al. |
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report. |
2018 |
J Med Case Rep |
pmid:29743095
|
Chen J et al. |
Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene. |
2018 |
Ann. Clin. Microbiol. Antimicrob. |
pmid:29562911
|
RodrÃguez-Sevilla G et al. |
Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model. |
2018 |
Int. J. Med. Microbiol. |
pmid:29555180
|
Leung WK et al. |
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals. |
2018 |
Gastroenterology |
pmid:29550592
|
Kusuki M et al. |
Determination of the antimicrobial susceptibility and molecular profile of clarithromycin resistance in the Mycobacterium abscessus complex in Japan by variable number tandem repeat analysis. |
2018 |
Diagn. Microbiol. Infect. Dis. |
pmid:29550059
|
Brennan DE et al. |
Can bacterial virulence factors predict antibiotic resistant infection? |
2018 |
World J. Gastroenterol. |
pmid:29531461
|
Reisfeld L et al. |
Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis. |
2018 |
Dis. Aquat. Org. |
pmid:29516862
|
Fiorini G et al. |
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice. |
2018 |
Eur J Gastroenterol Hepatol |
pmid:29481383
|
Talarico S et al. |
High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. |
2018 |
Helicobacter |
pmid:29480566
|
Takemori N et al. |
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report. |
2018 |
J Med Case Rep |
pmid:29454372
|
Xu R et al. |
Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29453492
|
Tsutsui A et al. |
Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016. |
2018 |
J. Infect. Chemother. |
pmid:29428566
|
Tarhini M et al. |
First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy. |
2018 |
Microb. Pathog. |
pmid:29428426
|
Kobayashi T et al. |
The potential role of clarithromycin addition to lenalidomide and dexamethasone therapy (BiRd) in multiple myeloma. |
2018 |
Ann. Hematol. |
pmid:29427183
|
Wang S et al. |
Enhanced adsorption of ionizable antibiotics on activated carbon fiber under electrochemical assistance in continuous-flow modes. |
2018 |
Water Res. |
pmid:29426033
|
Yagbasan A et al. |
A Prospective, randomized study comparing 7-day and 14-day quadruple therapies as first-line treatments for helicobacter pylori infection in patients with functional dyspepsia. |
2018 |
Niger J Clin Pract |
pmid:29411724
|
Maiolino G et al. |
Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism. |
2018 |
Blood Press. |
pmid:29409357
|
Takahashi E et al. |
Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus. |
2018 |
Comp. Immunol. Microbiol. Infect. Dis. |
pmid:29406285
|
Wang YH et al. |
A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori. |
2018 |
Helicobacter |
pmid:29405526
|
Jung JH et al. |
Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Infection. |
2018 |
Gut Liver |
pmid:29212313
|
Deng J et al. |
Lack of additional effects of long-term, low-dose clarithromycin combined treatment compared with topical steroids alone for chronic rhinosinusitis in China: a randomized, controlled trial. |
2018 |
Int Forum Allergy Rhinol |
pmid:29195025
|
Beer-Davidson G et al. |
Detection of Helicobacter pylori in stool samples of young children using real-time polymerase chain reaction. |
2018 |
Helicobacter |
pmid:29181860
|
Muñoz-Gómez P et al. |
Macrolide use in the previous years is associated with failure to eradicate Helicobacter pylori with clarithromycin-containing regimens. |
2018 |
Helicobacter |
pmid:29178562
|
Zagari RM et al. |
Treatment of Helicobacter pylori infection: A clinical practice update. |
2018 |
Eur. J. Clin. Invest. |
pmid:29144559
|
Liu DS et al. |
Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study. |
2018 |
Clin. Microbiol. Infect. |
pmid:29138101
|
Redondo JJ et al. |
A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene. |
2018 |
Diagn. Microbiol. Infect. Dis. |
pmid:29111147
|
Iwamoto J et al. |
Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease. |
2018 |
Intern. Med. |
pmid:29093413
|
Ersoy B et al. |
The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs. |
2018 |
J Laryngol Otol |
pmid:29888693
|
Inagaki Y et al. |
Disseminated Cutaneous Infection of Mycobacterium colombiense in a Patient with Myelodysplastic Syndrome. |
2018 |
Intern. Med. |
pmid:29093379
|
De Francesco V et al. |
Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study. |
2018 |
Dig Liver Dis |
pmid:29089267
|
Cerqueira RM et al. |
Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery. |
2018 |
Obes Surg |
pmid:29076008
|
Haj Yahia S et al. |
Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. |
2018 |
Rheumatol. Int. |
pmid:28975396
|
Shaharir SS et al. |
Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus (SLE) patient: a case review and pooled case analysis. |
2018 |
Clin. Rheumatol. |
pmid:28971307
|
De Lorenzi G et al. |
Mycobacterium genavense Infection in a Domestic Ferret (Mustela putorius furo). |
2018 |
Top Companion Anim Med |
pmid:30502861
|
McNicholl AG et al. |
Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial. |
2018 |
Helicobacter |
pmid:30141228
|
Silva GM et al. |
Helicobacter pylori antimicrobial resistance in a pediatric population. |
2018 |
Helicobacter |
pmid:30091503
|
Bilgilier C et al. |
Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori. |
2018 |
Clin. Microbiol. Infect. |
pmid:28669844
|
Barros S et al. |
Cat Scratch Disease: Not a Benign Condition. |
2018 |
Ocul. Immunol. Inflamm. |
pmid:28665750
|
Ullah S et al. |
Hydrophilically modified self-assembling α-tocopherol derivative as niosomal nanocarrier for improving clarithromycin oral bioavailability. |
2018 |
Artif Cells Nanomed Biotechnol |
pmid:28541761
|
Sancak S et al. |
A pioneering study: oral clarithromycin treatment for feeding intolerance in very low birth weight preterm infants. |
2018 |
J. Matern. Fetal. Neonatal. Med. |
pmid:28279123
|
Yoshida S et al. |
Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan. |
2018 |
J. Med. Microbiol. |
pmid:29227218
|
Cheung KS et al. |
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for : a population-based study. |
2018 |
Gut |
pmid:29089382
|
Ribaldone DG et al. |
Helicobacter pylori eradication: poor medical compliance from East to West of the world. |
2018 |
Scand. J. Gastroenterol. |
pmid:29383955
|
Suzuki K et al. |
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare lung disease from post-marketing surveillance. |
2018 |
Respir Investig |
pmid:29325687
|